In agreement with other studies (6), we found Vpr did not enhance HIV-1 virion production in the first-round infection in MDMs but enhanced HIV-1 Env processing to produce more infectious HIV-1 virions for the second-round infection (Fig. 1). Here, ERVW-1 is linked to infection.